4
Changes in Ownership
FATE THERAPEUTICS INC Filed Acc 0001209191-23-041611
Chief Commercial Officer sold 3,854 shares at $4.87 ($18,769)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Powl Brian T. Chief Commercial Officer | 2023-07-05 | Sale | −3,854 | $4.87 | $18,769 | 41,146 | D |
| Open-market sales · 3,854 sh · avg $4.87 · $18,769 | |||||||
Loading xslF345X04/doc4.xml…